KEAP1 anticorps (C-Term)
Aperçu rapide pour KEAP1 anticorps (C-Term) (ABIN4889301)
Antigène
Voir toutes KEAP1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- Reacts with KEAP1 from human, pig, guinea pig, sheep and other species (due to 100 % sequence homology)
-
Purification
- Purified (protein A)
-
Immunogène
- Synthetic peptide of derived from C terminal part of human KEAP1.
-
-
-
-
Indications d'application
-
Working dilution: Optimal dilutions should be determined by the end user.
The following are guidelines only:
WB(1:500 - 1:200) ICC/ IF(1:200 - 1:1000) -
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Must be reconstituted in distilled water.
-
Concentration
- 1 mg/mL
-
Buffer
- Tris 0,1M, glycine 0,1M
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Short term storage at+4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt.
-
Date de péremption
- 6 months
-
-
- KEAP1 (Kelch-Like ECH-Associated Protein 1 (KEAP1))
-
Autre désignation
- KEAP1
-
Sujet
- Acts as a substrate adapter protein for the E3 ubiquitin ligase complex formed by CUL3 and RBX1 and targets NFE2L2/NRF2 for ubiquitination and degradation by the proteasome, thus resulting in the suppression of its transcriptional activity and the repression of antioxidant response element-mediated detoxifying enzyme gene expression. Retains NFE2L2/NRF2 and may also retain BPTF in the cytosol. Targets PGAM5 for ubiquitination and degradation by the proteasome.
-
ID gène
- 9817
-
UniProt
- Q14145
-
Pathways
- Maintenance of Protein Location
Antigène
-